Information for Clinicians on Investigational Therapeutics for Patients with COVID-19
Excerpt…
The spectrum of medical therapies to treat coronavirus disease 2019 (COVID-19) is growing and evolving rapidly, including both drugs approved by U.S. Food and Drug Administration (FDA) and drugs made available under FDA emergency use authorization (EUA). CDC strongly encourages clinicians, patients and their advocates, and health system administrators to regularly consult the COVID-19 Treatment Guidelines published by the National Institutes of Health (NIH).
Information for U.S. Healthcare Facilities about Coronavirus (COVID-19)
CDC COVID-19 Homepage
Coronavirus Disease 2019 (COVID-19) Update and Infection Prevention and Control Recommendations
Excerpt…
During this COCA Call, presenters will focus on current information about COVID-19 and provide clinicians with updated information on implementing infection prevention and control measures, assessing risks for exposures, and optimizing the use of personal protective equipment supplies.
Information for Healthcare Professionals about Coronavirus (COVID-19)
Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States
Excerpt…
The Advisory Committee on Immunization Practices (ACIP) has issued interim recommendations for the use of Pfizer-BioNTech and Moderna COVID-19 vaccines for the prevention of coronavirus disease 2019 (COVID-19) in the United States. Both vaccines are lipid nanoparticle-formulated, nucleoside-modified mRNA vaccines encoding the prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19.